These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23474764)

  • 1. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.
    Allen-Petersen BL; Carter CJ; Ohm AM; Reyland ME
    Oncogene; 2014 Mar; 33(10):1306-15. PubMed ID: 23474764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.
    Ma Z; Parris AB; Howard EW; Shi Y; Yang S; Jiang Y; Kong L; Yang X
    Carcinogenesis; 2018 Oct; 39(10):1264-1273. PubMed ID: 30107476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
    Mancini ML; Lien EC; Toker A
    Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
    Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
    Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
    Boulay PL; Mitchell L; Turpin J; Huot-Marchand JÉ; Lavoie C; Sanguin-Gendreau V; Jones L; Mitra S; Livingstone JM; Campbell S; Hallett M; Mills GB; Park M; Chodosh L; Strathdee D; Norman JC; Muller WJ
    Cancer Res; 2016 May; 76(9):2662-74. PubMed ID: 26933086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity.
    Kuang X; Salinger A; Benavides F; Muller WJ; Dent SYR; Koutelou E
    PLoS One; 2024; 19(1):e0290837. PubMed ID: 38236941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
    Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2 is required for ductal morphogenesis of the mammary gland.
    Jackson-Fisher AJ; Bellinger G; Ramabhadran R; Morris JK; Lee KF; Stern DF
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17138-43. PubMed ID: 15569931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
    Chen H; Pimienta G; Gu Y; Sun X; Hu J; Kim MS; Chaerkady R; Gucek M; Cole RN; Sukumar S; Pandey A
    Proteomics; 2010 Nov; 10(21):3800-10. PubMed ID: 20960451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice.
    Yang H; Wang X; Blanco-Gómez A; He L; García-Sancha N; Corchado-Cobos R; Pérez-Baena MJ; Jiménez-Navas A; Wang P; Inman JL; Snijders AM; Threadgill DW; Balmain A; Chang H; Perez-Losada J; Mao JH
    EBioMedicine; 2024 Aug; 106():105260. PubMed ID: 39067134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYB is essential for mammary tumorigenesis.
    Miao RY; Drabsch Y; Cross RS; Cheasley D; Carpinteri S; Pereira L; Malaterre J; Gonda TJ; Anderson RL; Ramsay RG
    Cancer Res; 2011 Nov; 71(22):7029-37. PubMed ID: 21948968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor loss impairs mammary tumorigenesis in mice.
    Podmore L; Poloz Y; Iorio C; Mouaaz S; Nixon K; Smirnov P; McDonnell B; Lam S; Zhang B; Tharmapalan P; Sarkar S; Vyas F; Ennis M; Dowling R; Stambolic V
    Cell Rep; 2023 Nov; 42(11):113251. PubMed ID: 37913774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer.
    Chaib M; Holt JR; Fisher EL; Sipe LM; Bohm MS; Joseph SC; Simmons BW; Eugin Simon S; Yarbro JR; Tanveer U; Halle JL; Carson JA; Hollingsworth TJ; Wei Q; Rathmell JC; Thomas PG; Hayes DN; Makowski L
    Sci Adv; 2023 Dec; 9(51):eadd3231. PubMed ID: 38134280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for cancer pathogenesis and therapy.
    Speidel JT; Affandi T; Jones DNM; Ferrara SE; Reyland ME
    Adv Biol Regul; 2020 Dec; 78():100757. PubMed ID: 33045516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment.
    Yuan H; Wang X; Lu J; Zhang Q; Brandina I; Alexandrov I; Glazer RI
    Oncotarget; 2018 Jan; 9(8):8042-8053. PubMed ID: 29487713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the Shared and Context-Dependent Pathways Mediated by the p140Cap Adaptor Protein in Cancer and in Neurons.
    Chapelle J; Sorokina O; McLean C; Salemme V; Alfieri A; Angelini C; Morellato A; Adrait A; Menna E; Matteoli M; Couté Y; Ala U; Turco E; Defilippi P; Armstrong JD
    Front Cell Dev Biol; 2019; 7():222. PubMed ID: 31681758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein kinase C delta leads to cellular senescence to induce anti-tumor effects in colorectal cancer.
    Shimoyama Y; Yamada K; Yoshida S; Kawamura A; Hannya Y; Imaizumi Y; Kumamoto T; Takeda Y; Shimoda M; Eto K; Yoshida K
    Cancer Sci; 2023 Jun; 114(6):2471-2484. PubMed ID: 36851883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status.
    Bader JM; Deigendesch N; Misch M; Mann M; Koch A; Meissner F
    Cell Rep Med; 2023 Jan; 4(1):100877. PubMed ID: 36584682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancer.
    Zuo YH; Gao WN; Xie YJ; Yang SY; Zhou JT; Liang HH; Fan XX
    BMC Med; 2022 Dec; 20(1):470. PubMed ID: 36482371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model.
    Loots DT; Adeniji AA; Van Reenen M; Ozturk M; Brombacher F; Parihar SP
    Metabolomics; 2022 Nov; 18(11):92. PubMed ID: 36371785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.